Quarterly Accounts Payable, Current in USD from Q4 2010 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary: Heron Therapeutics, Inc. /De/ quarterly Accounts Payable, Current history and growth rate from Q4 2010 to Q3 2024.
Heron Therapeutics, Inc. /De/ Accounts Payable, Current for the quarter ending September 30, 2024 was $10.2M, a 448% increase year-over-year.

Accounts Payable, Current, Quarterly (USD)

Accounts Payable, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$10.2M	+$8.33M	+448%	Sep 30, 2024	10-Q	2024-11-12
Q2 2024	$10.2M	+$8.27M	+423%	Jun 30, 2024	10-Q	2024-08-06
Q1 2024	$837K	-$3.23M	-79.4%	Mar 31, 2024	10-Q	2024-05-07
Q4 2023	$3.24M	+$15K	+0.47%	Dec 31, 2023	10-Q	2024-11-12
Q3 2023	$1.86M	-$4.69M	-71.6%	Sep 30, 2023	10-Q	2023-11-14
Q2 2023	$1.96M	-$11.8M	-85.8%	Jun 30, 2023	10-Q	2023-08-14
Q1 2023	$4.07M	-$4.16M	-50.6%	Mar 31, 2023	10-Q	2023-05-11
Q4 2022	$3.23M	-$578K	-15.2%	Dec 31, 2022	10-K	2024-03-12
Q3 2022	$6.55M	+$662K	+11.2%	Sep 30, 2022	10-Q	2022-11-08
Q2 2022	$13.8M	+$2.56M	+22.8%	Jun 30, 2022	10-Q	2022-08-09
Q1 2022	$8.23M	+$6.54M	+387%	Mar 31, 2022	10-Q	2022-05-09
Q4 2021	$3.8M	+$3.28M	+624%	Dec 31, 2021	10-K	2023-03-29
Q3 2021	$5.89M	-$6.18M	-51.2%	Sep 30, 2021	10-Q	2021-11-03
Q2 2021	$11.2M	-$7.22M	-39.1%	Jun 30, 2021	10-Q	2021-08-09
Q1 2021	$1.69M	-$9.87M	-85.4%	Mar 31, 2021	10-Q	2021-05-10
Q4 2020	$525K	-$2.23M	-81%	Dec 31, 2020	10-K	2022-02-28
Q3 2020	$12.1M	+$10.4M	+642%	Sep 30, 2020	10-Q	2020-11-05
Q2 2020	$18.5M	+$10.5M	+131%	Jun 30, 2020	10-Q	2020-08-05
Q1 2020	$11.6M	+$751K	+6.95%	Mar 31, 2020	10-Q	2020-05-06
Q4 2019	$2.76M	-$14.1M	-83.6%	Dec 31, 2019	10-K	2021-02-24
Q3 2019	$1.63M	-$8.02M	-83.1%	Sep 30, 2019	10-Q	2019-11-12
Q2 2019	$8M	+$3.02M	+60.6%	Jun 30, 2019	10-Q	2019-08-05
Q1 2019	$10.8M	-$647K	-5.65%	Mar 31, 2019	10-Q	2019-05-09
Q4 2018	$16.9M	-$1.91M	-10.2%	Dec 31, 2018	10-K	2020-03-02
Q3 2018	$9.64M	+$4.31M	+80.7%	Sep 30, 2018	10-Q	2018-11-07
Q2 2018	$4.98M	-$1.34M	-21.2%	Jun 30, 2018	10-Q	2018-08-08
Q1 2018	$11.5M	+$6.98M	+156%	Mar 31, 2018	10-Q	2018-05-10
Q4 2017	$18.8M	+$12M	+175%	Dec 31, 2017	10-K	2019-02-22
Q3 2017	$5.34M	-$753K	-12.4%	Sep 30, 2017	10-Q	2017-11-06
Q2 2017	$6.32M	-$2.35M	-27.1%	Jun 30, 2017	10-Q	2017-08-09
Q1 2017	$4.48M	-$2.38M	-34.7%	Mar 31, 2017	10-Q	2017-05-10
Q4 2016	$6.81M	+$3.51M	+106%	Dec 31, 2016	10-K	2018-02-27
Q3 2016	$6.09M	+$3.36M	+123%	Sep 30, 2016	10-Q	2016-11-08
Q2 2016	$8.66M	+$5.67M	+190%	Jun 30, 2016	10-Q	2016-08-08
Q1 2016	$6.86M	+$4.48M	+188%	Mar 31, 2016	10-Q	2016-05-05
Q4 2015	$3.3M	+$751K	+29.5%	Dec 31, 2015	10-K	2017-02-23
Q3 2015	$2.74M	+$1.26M	+85.4%	Sep 30, 2015	10-Q	2015-11-06
Q2 2015	$2.99M	+$1.22M	+68.9%	Jun 30, 2015	10-Q	2015-08-07
Q1 2015	$2.38M	-$1.22M	-33.9%	Mar 31, 2015	10-Q	2015-05-08
Q4 2014	$2.55M	+$1.29M	+102%	Dec 31, 2014	10-K	2016-02-19
Q3 2014	$1.48M	-$775K	-34.4%	Sep 30, 2014	10-Q	2014-11-06
Q2 2014	$1.77M	-$3.58M	-66.9%	Jun 30, 2014	10-Q	2014-08-04
Q1 2014	$3.6M	-$222K	-5.8%	Mar 31, 2014	10-Q	2014-05-12
Q4 2013	$1.26M	-$648K	-33.9%	Dec 31, 2013	10-K	2015-03-13
Q3 2013	$2.25M	+$492K	+28%	Sep 30, 2013	10-Q	2013-11-12
Q2 2013	$5.35M	+$4.75M	+784%	Jun 30, 2013	10-Q	2013-08-08
Q1 2013	$3.83M	+$2.94M	+330%	Mar 31, 2013	10-Q	2013-05-10
Q4 2012	$1.91M	+$902K	+89.3%	Dec 31, 2012	10-K	2014-03-07
Q3 2012	$1.76M	+$1.33M	+306%	Sep 30, 2012	10-Q	2012-11-05
Q2 2012	$605K	+$316K	+109%	Jun 30, 2012	10-Q	2012-08-09
Q1 2012	$890K			Mar 31, 2012	10-Q	2012-05-10
Q4 2011	$1.01M	+$851K	+535%	Dec 31, 2011	10-K	2013-03-01
Q3 2011	$433K			Sep 30, 2011	10-Q	2011-11-07
Q2 2011	$289K			Jun 30, 2011	10-Q	2011-08-08
Q4 2010	$159K			Dec 31, 2010	10-K	2012-03-26

* An asterisk sign (*) next to the value indicates that the value is likely invalid.